Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FlightPlan for Embolization

K-Number: K223490 · 2023-03-21

Decision Date2023-03-21
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

FlightPlan for Embolization is a medical device manufactured by GE Medical Systems SCS. It received FDA 510(k) clearance on 2023-03-21 under approval number K223490. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FlightPlan for Embolization?

FlightPlan for Embolization is a medical device that received FDA 510(k) clearance on 2023-03-21. It is manufactured by GE Medical Systems SCS. The 510(k) number is K223490.

When was FlightPlan for Embolization approved by the FDA?

FlightPlan for Embolization received FDA 510(k) clearance on 2023-03-21, under approval number K223490.

What company makes FlightPlan for Embolization?

FlightPlan for Embolization is manufactured by GE Medical Systems SCS.

What is the FDA product code for FlightPlan for Embolization?

The FDA product code for FlightPlan for Embolization is LLZ.

Other Devices by GE Medical Systems SCS

View all 27 devices →

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.